Edesa Biotech, Inc. (EDSA) › Operating Cash FlowEdesa Biotech, Inc. (EDSA) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2015: -$4.41M2016: -$4.51M2017: -$4.70M2018: -$1.29M2020: -$4.99M2021: -$13.66M2022: -$12.28M2023: -$6.64M2024: -$4.89M2025: -$7.32M-$7.32M2015Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$7.32M-49.7%2024-$4.89M+26.3%2023-$6.64M+46.0%2022-$12.28M+10.1%2021-$13.66M-174.0%2020-$4.99M—2018-$1.29M+72.6%2017-$4.70M-4.3%2016-$4.51M-2.1%2015-$4.41M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share